Sublobar resection for early-stage non-small cell lung cancer has been an emerging topic of great interest to thoracic surgeons. However, data regarding the efficacy and safety of sublobar resection vs lobectomy was lacking until now. Recently, 3 published randomized controlled trials (Cancer and Leukemia Group B [CALGB]140503/Alliance, Japan Clinical Oncology Group [JCOG]0802 and Das Deutsche Register Klinischer Studien [DRKS]00004897) confirmed the noninferiority of sublobar resection for early-stage non-small cell lung cancer in carefully selected populations. This review aims to summarize and compare these 3 landmark trials and inform surgeons of new best practices.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2023.12.008DOI Listing

Publication Analysis

Top Keywords

sublobar resection
16
non-small cell
12
cell lung
12
resection lobectomy
8
resection early-stage
8
early-stage non-small
8
lung cancer
8
sublobar
4
lobectomy stage
4
stage non-small
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!